USP 1079: Building a Pharmacy Quality System Around Medication Storage and Transportation

Medication storage is often treated as a refrigerator log, a room-temperature reading, or a line in a policy. USP 1079 presents a much broader view.

USP General Chapter <1079>, Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products, addresses the systems, people, facilities, equipment, documentation, and handoffs involved in protecting finished medications throughout the supply chain. Its scope includes temperature-sensitive small molecules, vaccines, biologics, radiopharmaceuticals, biotechnology products, and combination products.

For pharmacy leaders, the most important lesson is that medication storage does not begin when a product is placed on a pharmacy shelf. It begins with supplier qualification and shipment planning, continues through receiving and internal distribution, and extends to clinics, nursing units, couriers, patients, and other destinations.

USP <1079> can therefore influence far more than temperature monitoring. It can shape:

Employee onboarding and competency
Receiving-department relationships
Vendor and courier oversight
Storage-area qualification
Excursion investigations
Emergency preparedness
Documentation practices
Corrective and preventive action
The pharmacy’s overall quality management system

What Do USP Chapters Above 1000 Mean?

USP general chapters numbered below <1000> may become applicable compendial requirements when referenced by a monograph, another applicable chapter, or USP General Notices. Chapters numbered from <1000> through <1999> are generally categorized as informational chapters rather than independently mandatory requirements.

That distinction is important, but it should not lead pharmacy teams to dismiss chapters such as USP <1079>.

An informational chapter can provide a recognized framework for designing policies, evaluating risk, training personnel, selecting equipment, managing vendors, and documenting quality decisions. It may also influence expectations established by:

State boards of pharmacy
Accreditation organizations
Health-system policies
Manufacturer agreements
Payer or specialty-pharmacy contracts
Internal quality and patient-safety programs

A pharmacy should verify which requirements apply to its jurisdiction, practice setting, contracts, and accreditation programs. Even when USP <1079> is not directly enforceable as a standalone chapter, its risk-based concepts can help a pharmacy build a more consistent and defensible quality system.

What Does USP 1079 Cover?

USP <1079> approaches storage and transportation as parts of an integrated supply chain. The chapter recognizes that finished medications may pass through numerous organizations, environments, vehicles, facilities, and individuals before reaching the patient.

For pharmacies, the chapter’s concepts can be organized into several operational areas.

Quality Management and Written Procedures

A pharmacy’s quality system should define how medication storage and transportation risks are identified, controlled, documented, and reviewed.

Relevant procedures may address:

Product receipt and inspection
Temperature monitoring
Storage-area access
Alarm response
Product quarantine
Temperature excursions
Emergency relocation
Transportation and courier controls
Product returns
Vendor qualification
Calibration and maintenance
Staff training
Deviation investigation
Corrective and preventive action

The goal is not simply to create more policies. The goal is to connect responsibilities, monitoring records, investigations, and corrective actions into one functioning system.

Personnel Responsibilities and Training

Storage and transportation controls depend on people making consistent decisions. That includes individuals outside the pharmacy department.

Employees who may affect medication quality include:

Pharmacy staff
Receiving personnel
Materials-management teams
Nursing staff
Clinic employees
Security personnel
Facilities and engineering staff
Environmental services
Drivers and couriers
Third-party logistics vendors

Training should be appropriate to each role. A receiving employee may not need an advanced explanation of pharmaceutical stability, but that employee should know how to identify a temperature-sensitive package, where to place it, what damage to inspect for, and whom to notify if a shipment arrives late, warm, frozen, wet, crushed, or without expected monitoring data.

Facilities, Storage Areas, and Equipment

Storage locations should be appropriate for the products kept within them. This may involve more than confirming that a refrigerator displays a temperature within range.

A pharmacy may need to evaluate:

Airflow and temperature distribution
Proximity to exterior doors
Direct sunlight
Heating or cooling vents
Seasonal conditions
Loading docks
Backup power
Door-opening frequency
Overstocking
Equipment maintenance
Monitoring-probe placement
Alarm notification pathways
Access during evenings and weekends

A device reading is only useful when the device is properly placed, maintained, calibrated, reviewed, and connected to an effective response process. For example, responsible personnel for responding to temperature excursions should have proper access to the alarming as well as access to the area to be able to respond.

Transportation and Internal Distribution

Medication transportation can include wholesaler shipments, transfers between pharmacies, movement to hospital units, courier delivery, mail-order distribution, clinic replenishment, home-infusion delivery, and shipment directly to patients.

Each handoff introduces potential risks involving:

Temperature
Delay
Package damage
Light exposure
Humidity
Security
Chain of custody
Incorrect destination
Failure to retrieve a package
Unattended delivery
Inadequate packaging

Pharmacies should determine what level of control is appropriate based on the product, shipping duration, environmental conditions, packaging system, destination, and consequences of a failure.

How USP 1079 Relates to USP 659

USP <659>, Packaging and Storage Requirements, provides standardized definitions for packaging and labeled storage conditions. Its purpose includes defining storage terminology relevant to active ingredients, excipients, pharmaceuticals, combination products, and other medical products.

In practical terms, USP <659> helps define what the storage conditions mean, while USP <1079> helps organizations think about how to manage the risks involved in maintaining those conditions.

For example, USP <659> provides the vocabulary used for labeled conditions such as controlled room temperature, cold, refrigerator, freezer, and protection from light. USP <1079> can then help the pharmacy develop systems for:

Maintaining those conditions
Selecting monitoring equipment
Evaluating storage locations
Responding to alarms
Investigating excursions
Managing transportation risks
Documenting disposition decisions

Pharmacy teams should avoid converting a labeled storage range into a simplistic alarm policy without considering device accuracy, response time, normal operating variation, product risk, and the location’s actual performance.

For a deeper explanation of labeled storage terminology, see Pestle’s article on USP 659 Packaging and Storage Requirements for Pharmacies.

USP 1079.2 and Mean Kinetic Temperature

USP <1079.2>, Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products, focuses on the use of mean kinetic temperature, commonly abbreviated as MKT, when evaluating certain temperature histories.

The chapter explains that product degradation depends on factors including product stability, packaging, storage, and shipping conditions. Temperature may vary during a product’s life, and those variations can affect degradation pathways and critical quality attributes.

What Is Mean Kinetic Temperature?

Mean kinetic temperature is not a simple arithmetic average.

MKT is a calculated temperature that represents the cumulative thermal stress experienced over time. The calculation gives greater weight to higher temperatures because many degradation reactions accelerate as temperature increases.

Consider two storage histories that both have an arithmetic average of 25°C:

One location remains close to 25°C throughout the period.
Another repeatedly moves between much cooler and much warmer temperatures.

Those histories may not create the same degradation risk. MKT is designed to better reflect the potential effect of the warmer periods than a standard average would.

When May MKT Be Useful?

MKT may be useful as one component of a scientifically supported excursion assessment when:

Complete time-and-temperature data are available
The product’s labeled storage conditions are understood
The duration and magnitude of the excursion are known
The product’s stability characteristics are relevant to the calculation
Qualified personnel review the result
Manufacturer or other authoritative stability information is available
The pharmacy follows an approved excursion-investigation process

MKT may help evaluate cumulative exposure during storage or transportation, particularly when temperatures fluctuate over time rather than remaining at one constant out-of-range temperature.

When Should MKT Not Be Used by Itself?

MKT should not be treated as an automatic release calculation or as permission to disregard an alarm.

A favorable MKT value does not necessarily address every quality risk. MKT may be inappropriate or insufficient when:

A product may have frozen
The temperature exceeded a known critical limit
The excursion involved extreme heat
The data record is incomplete
The monitoring device failed
The product is sensitive to brief temperature spikes
Light, humidity, vibration, or physical damage may also be involved
The manufacturer requires direct consultation
Product-specific stability information does not support the conclusion

The result should be interpreted within a documented, product-specific risk assessment. Final disposition may require consultation with the manufacturer, wholesaler, sponsor, or other qualified authority.

Why Continuous Temperature Monitoring Matters

Manual temperature logs can show that someone looked at a display at a particular time. They do not necessarily show what happened between observations. A good quality management system can best assess when a continuous temperature monitor is more appropriate than daily checks. For example, the risk of a refrigerator going out of range unnoticed that has an alarm in a 24 hour staffed pharmacy will be less than a remote clinic closed on the weekend.

Continuous monitoring can provide a more complete temperature history, including:

Overnight events
Weekend failures
Door-related fluctuations
Gradual equipment deterioration
Power interruptions
Defrost cycles
Seasonal patterns
Repeated near-limit conditions
The duration of an excursion
The highest and lowest recorded values

This information can improve both immediate response and long-term quality management.

A single alarm may show that something went wrong. A continuous data record can help show when it started, how long it lasted, how severe it was, whether it has happened before, and whether corrective action was effective.

Continuous monitoring also creates opportunities for trending. A refrigerator that remains technically within range but operates progressively closer to the upper boundary may warrant maintenance or adjustments before an actual excursion occurs.

The technology itself, however, is only one part of the control. The pharmacy still needs procedures for alarm routing, escalation, response time, after-hours coverage, data retention, calibration, probe placement, system testing, and downtime.

How USP 1079 Can Influence Employee Onboarding

Storage and transportation responsibilities should be introduced during onboarding rather than taught only after a temperature excursion occurs.

A role-based onboarding program may include:

For Pharmacy Personnel

Understanding labeled storage conditions
Reviewing monitoring systems and alarm limits
Responding to alerts
Quarantining affected medication
Documenting investigations
Escalating disposition decisions
Managing refrigerator and freezer organization
Preparing products for internal or external transport

For Receiving Personnel

Identifying medication shipments
Prioritizing refrigerated, frozen, or otherwise sensitive products
Inspecting packaging and seals
Locating temperature indicators or data loggers
Recording delivery times
Recognizing damaged or delayed shipments
Contacting pharmacy personnel immediately

For Couriers and Drivers

Maintaining required transportation conditions
Protecting packages from unattended exposure
Following chain-of-custody procedures
Reporting delays or vehicle problems
Avoiding unauthorized package opening
Documenting delivery and failed-delivery events

Competency should be demonstrated when practical. A short quiz may confirm knowledge, but a simulated damaged shipment or refrigerator alarm can better reveal whether employees know what to do.

Strengthening the Relationship With the Receiving Department

Receiving is one of the most important medication-quality handoffs in a hospital or health system.

A shipment may arrive at a loading dock rather than directly in the pharmacy. During that interval, medication quality may depend on someone who does not report to the director of pharmacy.

Pharmacy and receiving leaders should jointly define:

Which packages receive priority handling
How temperature-sensitive shipments are identified
Who may sign for medication deliveries
Where packages are staged
Maximum acceptable staging time
What to do when the pharmacy is closed
How damaged shipments are handled
How monitoring devices are preserved
Who contacts the wholesaler or manufacturer
How delivery deviations are documented

These expectations should appear in written procedures and orientation materials. Periodic tracer exercises can test whether the process works in practice.

A useful tracer may begin with a refrigerated package arriving after normal pharmacy receiving hours. The organization should be able to follow the shipment from delivery through inspection, storage, documentation, and resolution of any abnormalities.

Incorporating USP 1079 Into the Pharmacy QMS

USP <1079> is most valuable when its concepts are integrated into the pharmacy’s quality management system rather than assigned exclusively to the temperature-log.

Document Control

Storage, receiving, transportation, excursion, and emergency procedures should have designated owners, approval dates, review cycles, and version histories.

Deviation Management

Temperature excursions, delayed shipments, damaged packages, equipment failures, and monitoring gaps should enter a consistent deviation process.

Corrective and Preventive Action

An excursion investigation should look beyond the affected product. It should determine whether the event reveals a broader system problem.

Potential corrective actions may include:

Repairing or replacing equipment
Moving a probe
Changing alarm thresholds
Updating escalation contacts
Retraining receiving staff
Revising courier instructions
Changing package configuration
Adding backup power
Increasing monitoring frequency
Requalifying a storage area

Change Control

Changes to storage equipment, shelving, probe locations, alarm software, packaging, couriers, suppliers, or delivery routes should be evaluated before implementation.

Vendor Qualification

Wholesalers, couriers, monitoring vendors, calibration providers, and third-party logistics organizations can affect medication quality. Vendor oversight may consider:

Service capabilities
Quality agreements
Performance history
Calibration practices
Incident notification
Data availability
Escalation procedures
Corrective-action responsiveness

Management Review

Leadership should periodically review more than whether temperatures remained in range.

Useful quality indicators may include:

Number of excursions
Alarm-response times
Repeat equipment failures
Delayed shipment frequency
Product loss
Open investigations
CAPA completion
Calibration status
Training completion
Vendor-related deviations
Trends by location or equipment type

A Practical USP 1079 Readiness Checklist

Pharmacy leaders can begin by asking:

Have we identified every location where medications are received, stored, staged, transported, or delivered?
Are responsibilities clear across pharmacy, receiving, nursing, facilities, security, and couriers?
Do our policies use storage terminology consistently with USP <659> and manufacturer labeling?
Are our storage areas and monitoring-probe locations supported by documented evaluation or, at least, a consistent and repeatable evaluation?
Do we have continuous monitoring where product and operational risks justify it?
Can the right person receive and respond to an alarm after hours?
Do excursion investigations include duration, magnitude, product, packaging, and stability information?
Is MKT used only within an approved and scientifically supported process? When is the manufacture consulted?
Are equipment failures and transportation deviations incorporated into CAPA?
Does leadership review trends rather than isolated temperature logs?

How Pestle Can Help

Pestle Compliance is designed to help pharmacy teams organize recurring compliance activities, assign responsibilities, document completion, and maintain evidence across locations, equipment, and personnel.

For a storage and transportation program, teams can use structured compliance workflows to support activities such as:

Daily temperature logging
Periodic monitoring reviews
Equipment inspection
Alarm testing guidance and documentation
Calibration reminders
Receiving audits
Staff competencies
Excursion investigations
Emergency-plan reviews
Vendor assessments
CAPA follow-up
Policy review schedules

Technology does not replace product labeling, qualified professional judgment, manufacturer consultation, or applicable legal and regulatory requirements. It can, however, help teams create a repeatable system in which responsibilities and evidence are easier to track.

As pharmacy monitoring systems become more connected, continuous-monitoring integrations may also create opportunities to connect environmental data with compliance workflows, escalation steps, investigations, and trend review.

Conclusion

USP <1079> is not simply a chapter about refrigerators.

It provides a framework for understanding how medication quality can be affected by people, facilities, equipment, packaging, transportation, vendors, and organizational handoffs. USP <1079.2> adds an important tool for evaluating certain temperature histories through mean kinetic temperature, but MKT must be used carefully and within a documented product-specific assessment.

A strong program connects USP <659> storage terminology, continuous monitoring, receiving practices, onboarding, excursion management, CAPA, vendor oversight, and leadership review.

Pharmacies that take this broader approach can move beyond collecting temperature readings and begin building a coordinated quality system designed to protect medications throughout their journey.

To explore how Pestle can help standardize pharmacy compliance activities and documentation, visit Pestle Compliance or request a personalized demo.

USP 1079: Storage, Transportation, MKT, and Pharmacy Quality

Table of Contents